1. Home
  2. PRPH vs CWD Comparison

PRPH vs CWD Comparison

Compare PRPH & CWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPH
    SELLHOLDBUYas of 14 hours ago
  • CWD
    SELLHOLDBUYas of 14 hours ago
  • Stock Information
  • Founded
  • PRPH 1989
  • CWD 2009
  • Country
  • PRPH United States
  • CWD United States
  • Employees
  • PRPH N/A
  • CWD N/A
  • Industry
  • PRPH Biotechnology: Pharmaceutical Preparations
  • CWD Real Estate
  • Sector
  • PRPH Health Care
  • CWD Finance
  • Exchange
  • PRPH Nasdaq
  • CWD Nasdaq
  • Market Cap
  • PRPH 10.7M
  • CWD 12.1M
  • IPO Year
  • PRPH 1997
  • CWD 2023
  • Fundamental
  • Price
  • PRPH $0.27
  • CWD $0.53
  • Analyst Decision
  • PRPH
  • CWD
  • Analyst Count
  • PRPH 0
  • CWD 0
  • Target Price
  • PRPH N/A
  • CWD N/A
  • AVG Volume (30 Days)
  • PRPH 3.1M
  • CWD 380.7K
  • Earning Date
  • PRPH 05-08-2025
  • CWD 05-08-2025
  • Dividend Yield
  • PRPH N/A
  • CWD N/A
  • EPS Growth
  • PRPH N/A
  • CWD N/A
  • EPS
  • PRPH N/A
  • CWD N/A
  • Revenue
  • PRPH $6,770,000.00
  • CWD $51,119,000.00
  • Revenue This Year
  • PRPH $221.82
  • CWD N/A
  • Revenue Next Year
  • PRPH N/A
  • CWD $35.22
  • P/E Ratio
  • PRPH N/A
  • CWD N/A
  • Revenue Growth
  • PRPH N/A
  • CWD N/A
  • 52 Week Low
  • PRPH $0.22
  • CWD $0.37
  • 52 Week High
  • PRPH $7.48
  • CWD $1.04
  • Technical
  • Relative Strength Index (RSI)
  • PRPH 35.25
  • CWD 40.82
  • Support Level
  • PRPH $0.35
  • CWD $0.42
  • Resistance Level
  • PRPH $0.52
  • CWD $0.62
  • Average True Range (ATR)
  • PRPH 0.09
  • CWD 0.09
  • MACD
  • PRPH -0.02
  • CWD -0.01
  • Stochastic Oscillator
  • PRPH 8.03
  • CWD 29.29

Stock Price Comparison Chart: PRPH vs CWD

PRPH
CWD
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0246810121416PRPH VS CWD

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

About CWD CaliberCos Inc.

CaliberCos Inc is an asset management firm, whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. Majority of revenue is derived from Asset management fees segment.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use